AbbVie Inc. (ABBV) stock
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3090% above fair value
$294.55−0.48 (-0.16%)
Close on Nov 16, 2026Market cap $520.50BP/E 83.2Yield 2.26%
AbbVie price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
AbbVie's price to book ratio was 236.0× on Jul 31, 2025, against 41.0× a year earlier. Over the last 5 years it ranged from 8.8× to 236.0×, with a median of 18.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jul 31, 2025 | 236.0× | +183.7 |
| 2024 | Dec 31, 2024 | 52.2× | +29.5 |
| 2023 | Dec 29, 2023 | 22.7× | +4.8 |
| 2022 | Dec 30, 2022 | 18.0× | +0.2 |
| 2021 | Dec 31, 2021 | 17.8× | +6.5 |
| 2020 | Dec 31, 2020 | 11.2× | −30.4 |
| 2018 | Jul 31, 2018 | 41.6× | +18.3 |
| 2017 | Dec 29, 2017 | 23.3× | +7.4 |
| 2016 | Dec 30, 2016 | 15.8× | −4.0 |
| 2015 | Dec 31, 2015 | 19.9× | −2.8 |
| 2014 | Dec 31, 2014 | 22.7× | −0.9 |
| 2013 | Dec 31, 2013 | 23.6× | – |
See a number that looks wrong?